EquityZen Growth Technology Fund LLC - Series 1249
Raised
$300K
Investors
16
Min Invest
$10,007
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1249 is a Delaware-based pooled investment fund filed by EquityZen Advisors and managed by Philip Haslett, Richard Thoms, and Assure Fund Management II. This amended filing reports $300K raised from 16 investors with a $10K minimum investment under exemptions 506(b) and 3(c)(1). The entity is part of the EquityZen platform, which operates nearly 1,900 related pre-IPO investment vehicles.
This pre-IPO fund employs the standard 506(b)/3(c)(1) exemption structure common to retail-accessible private equity vehicles, with a $10K minimum positioned at the lower end of the institutional spectrum. The per-investor average of approximately $18.75K reflects EquityZen's platform model enabling broad retail participation in late-stage private company exposure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
